These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6547457)

  • 1. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.
    Maruyama I; Salem HH; Majerus PW
    J Clin Invest; 1984 Jul; 74(1):224-30. PubMed ID: 6547457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.
    Salem HH; Esmon NL; Esmon CT; Majerus PW
    J Clin Invest; 1984 Apr; 73(4):968-72. PubMed ID: 6323539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury.
    Annamalai AE; Stewart GJ; Hansel B; Memoli M; Chiu HC; Manuel DW; Doshi K; Colman RW
    Arteriosclerosis; 1986; 6(2):196-202. PubMed ID: 3954673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.
    Wilson DB; Salem HH; Mruk JS; Maruyama I; Majerus PW
    J Clin Invest; 1984 Mar; 73(3):654-8. PubMed ID: 6200498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
    Salem HH; Broze GJ; Miletich JP; Majerus PW
    J Biol Chem; 1983 Jul; 258(14):8531-4. PubMed ID: 6688078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin.
    Maruyama I; Majerus PW
    J Biol Chem; 1985 Dec; 260(29):15432-8. PubMed ID: 2999116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of thrombomodulin from human placenta.
    Salem HH; Maruyama I; Ishii H; Majerus PW
    J Biol Chem; 1984 Oct; 259(19):12246-51. PubMed ID: 6090461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.
    Maruyama I; Salem HH; Ishii H; Majerus PW
    J Clin Invest; 1985 Mar; 75(3):987-91. PubMed ID: 2984256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex interaction between factor Va-light chain and thrombomodulin in the regulation of protein C activation.
    Salem HH; Esmon NL; Esmon CT; Majerus PW
    Ann N Y Acad Sci; 1986; 485():221-7. PubMed ID: 3032043
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
    Owen WG; Esmon CT
    J Biol Chem; 1981 Jun; 256(11):5532-5. PubMed ID: 6894592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C inhibits endocytosis of thrombin-thrombomodulin complexes in A549 lung cancer cells and human umbilical vein endothelial cells.
    Maruyama I; Majerus PW
    Blood; 1987 May; 69(5):1481-4. PubMed ID: 3032308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR; Bock PE
    Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
    Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
    Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C.
    Hackeng TM; Hessing M; van 't Veer C; Meijer-Huizinga F; Meijers JC; de Groot PG; van Mourik JA; Bouma BN
    J Biol Chem; 1993 Feb; 268(6):3993-4000. PubMed ID: 8440691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to human protein C: effects on the biological activity of activated protein C and the thrombin-catalyzed activation of protein C1.
    Suzuki K; Matsuda Y; Kusumoto H; Nishioka J; Terada M; Yamashita T; Hashimoto S
    J Biochem; 1985 Jan; 97(1):127-38. PubMed ID: 2581938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII.
    Rao LV; Rapaport SI; Lorenzi M
    Blood; 1988 Mar; 71(3):791-6. PubMed ID: 3422831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.